These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 1496955

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomentingocele.
    Kaefer M, Pabby A, Kelly M, Darbey M, Bauer SB.
    J Urol; 1999 Sep; 162(3 Pt 2):1068-71. PubMed ID: 10458433
    [Abstract] [Full Text] [Related]

  • 3. Management of children with myelodysplasia: urological alternatives.
    Klose AG, Sackett CK, Mesrobian HG.
    J Urol; 1990 Dec; 144(6):1446-9. PubMed ID: 2231940
    [Abstract] [Full Text] [Related]

  • 4. Clean, intermittent catheterization of infants with neurogenic bladder.
    Joseph DB, Bauer SB, Colodny AH, Mandell J, Retik AB.
    Pediatrics; 1989 Jul; 84(1):78-82. PubMed ID: 2740179
    [Abstract] [Full Text] [Related]

  • 5. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children.
    Amark P, Bussman G, Eksborg S.
    Eur Urol; 1998 Aug; 34(2):148-53. PubMed ID: 9693251
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk factors for febrile urinary tract infection in children with myelodysplasia treated by clean intermittent catheterization.
    Seki N, Masuda K, Kinukawa N, Senoh K, Naito S.
    Int J Urol; 2004 Nov; 11(11):973-7. PubMed ID: 15509200
    [Abstract] [Full Text] [Related]

  • 9. [Combination of oxybutynin chloride (Ditropan) with intermittent catheterization in the treatment of neurogenic bladder in childhood: results on continence].
    De Castro R, Casolari E, Ricci S.
    Pediatr Med Chir; 1984 Nov; 6(6):795-803. PubMed ID: 6545593
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clean intermittent catheterization in the management of the neurogenic bladder in children.
    Cass AS, Luxenberg M, Gleich P, Johnson CF, Hagen S.
    J Urol; 1984 Sep; 132(3):526-8. PubMed ID: 6471189
    [Abstract] [Full Text] [Related]

  • 13. The value of urodynamic testing in the management of neonates with myelodysplasia: a prospective study.
    Sidi AA, Dykstra DD, Gonzalez R.
    J Urol; 1986 Jan; 135(1):90-3. PubMed ID: 3941475
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The uninhibited bladder in children: effect of treatment on recurrence of urinary infection and on vesicoureteral reflux resolution.
    Koff SA, Murtagh DS.
    J Urol; 1983 Dec; 130(6):1138-41. PubMed ID: 6606053
    [Abstract] [Full Text] [Related]

  • 18. The use of intravesical oxybutynin chloride in children with neurogenic bladder.
    Greenfield SP, Fera M.
    J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294
    [Abstract] [Full Text] [Related]

  • 19. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia.
    Kasabian NG, Vlachiotis JD, Lais A, Klumpp B, Kelly MD, Siroky MB, Bauer SB.
    J Urol; 1994 Apr; 151(4):944-5. PubMed ID: 8126833
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.